CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Globe Newswire•10/11/2026•08:30 ET
0
Key Highlights
- ➤CRISPR Therapeutics (CRSP) management to join Jefferies healthcare conference fireside chat November 17
- ➤Webcast scheduled for 10:00 a.m. GMT, with replay archived for 14 days
- ➤CASGEVY approved for eligible sickle cell disease and transfusion-dependent beta thalassemia patients
- ➤Pipeline spans hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative and rare diseases
- ➤CRISPR Therapeutics expanding gene-editing toolkit through proprietary SyNTase platform
ZUG, Switzerland and BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026 at 10:00 a.m. GMT.
A live webcast of the fireside chat will be available on the “Events & Presentations” page in the Investors section of the Company’s website at https://crisprtx.gcs-web.com/events. A replay of the webcast will be archived on the Company’s website for 14 days following the presentation.
Get started
Create a free account to read the full story.